Nanologica AB (publ) (STO:NICA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1600
-0.0090 (-5.33%)
Nov 3, 2026, 5:25 PM CET

Nanologica AB Revenue

Nanologica AB had revenue of 25.38M SEK in the quarter ending June 30, 2026, with 1,079.32% growth. In the year 2025, Nanologica AB had annual revenue of 21.05M, down -36.85%. That makes Nanologica AB the 36,054th largest company in the world by revenue and 477th in Sweden.

Revenue
21.05M
Revenue Growth
-36.85%
P/S Ratio
0.41
Revenue / Employee
1.80M
Employees
72
Market Cap
52.60M

Revenue Chart

Revenue by Geography

  • China 18.28M 86.5%
  • Turkey 1.52M 7.2%
  • Rest of The World 1.06M 5.0%
  • India 182.00K 0.9%
  • United States of America (USA) 77.00K 0.4%
Fiscal year ended Dec 31, 2025 See the full Nanologica AB breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202521.05M-12.28M-36.85%
Dec 31, 202433.33M26.09M360.03%
Dec 31, 20237.25M2.43M50.46%
Dec 31, 20224.82M-8.69M-64.35%
Dec 31, 202113.51M-6.52M-32.55%
Dec 31, 202020.03M5.81M40.87%
Dec 31, 201914.22M9.82M223.23%
Dec 31, 20184.40M-4.22M-48.93%
Dec 31, 20178.61M2.99M53.30%
Dec 31, 20165.62M-3.80M-40.37%
Dec 31, 20159.42M2.78M41.78%
Dec 31, 20146.65M-2.84M-29.90%
Dec 31, 20139.48M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Fluicell AB18.44M
NextCell Pharma AB10.78M
AcouSort AB9.31M
OncoZenge AB5.97M
Spago Nanomedical AB3.81M
Pila Pharma AB275.74K
Alzinova AB149.00K
Revenue Rankings

Nanologica AB News

More News